CEBIOTEX
CEBIOTEX is a Spain-based biotechnology company running 2 late-stage cancer trials of CEB-01 in pancreatic ductal adenocarcinoma.
Overview
CEBIOTEX, based in Barcelona, Spain, is a biotechnology company. Cebiotex is a biotechnology company that uses proprietary nanofibre engineering to deliver anti-tumour agents directly at surgical sites for local, post-surgical cancer therapy. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing CEB-01 in pancreatic ductal adenocarcinoma. The largest, NCT06986811 (CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours), plans to enrol 60 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyAscentawits Pharmaceuticals
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyCrinetics Pharmaceuticals
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyOncolytics Biotech
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.